Previous 10 |
Momenta Pharmaceuticals (NASDAQ: MNTA ) is scheduled to announce Q4 earnings results on Friday, February 22nd, before market open. The consensus EPS Estimate is -$0.49 (-372.2% Y/Y) and the consensus Revenue Estimate is $17.11M (-73.5% Y/Y). Over the last 2 years, MNTA has beaten EPS ...
Noteworthy events during the week of February 10 - 16 for healthcare investors. More news on: Momenta Pharmaceuticals, Inc., Motif Bio, AVEO Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...
CAMBRIDGE, Mass., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will release its financial results for ...
Study highlights ability of M281 to inhibit transfer of immunoglobulin G from maternal to fetal circulation in ex vivo placental perfusion model M281 currently being evaluated in an international Phase 2 study in Hemolytic Disease of the Fetus and Newborn (HDFN) CAMBRIDGE, Mass., Feb...
CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced the dosing of the first subject in the Pha...
NEW YORK, NY / ACCESSWIRE / September 12, 2018 / Major equities closed up on Tuesday, with strong performances from the energy and telecommunications sector, as investors continued to watch the situation in the U.S. and China. The Dow Jones Industrial Average climbed 0.44 percent to close a...
NEW YORK, NY / ACCESSWIRE / September 6, 2018 / Major U.S. equities were mixed on Wednesday with tech stocks posting worst daily drop since July dragging Nasdaq lower. The Dow Jones Industrial Average was up 0.09 percent to close at 25,974.99, while the S&P 500 Index decreased 0.28 perce...
News, Short Squeeze, Breakout and More Instantly...
Momenta Pharmaceuticals Inc. Company Name:
MNTA Stock Symbol:
NASDAQ Market:
Momenta Pharmaceuticals Inc. Website:
Are These Top 3 Pharmaceutical Stocks On Your October Watchlist? Investing in pharmaceutical stocks is a popular trend in times of political or economic instability. This is because the demand for drugs will still be steady all year long, no matter what is happening in the world...
Chesapeake Utilities to Join S&P SmallCap 600 Chesapeake Utilities to Join S&P SmallCap 600 PR Newswire NEW YORK, Sept. 25, 2020 NEW YORK , Sept. 25, 2020 /PRNewswire/ -- Chesapeake Utilities Corp (NYSE:CPK) will replace Momenta Pharmaceuticals In...
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...